Most Asian stocks up on big US-French drug merger

February 17, 2011 06:17


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

TOKYO  — Most Asian stock  markets were higher on Thursday as investors took heart from a major U.S.-French pharmaceutical merger and a raft of strong U.S. corporate earnings.

The Nikkei 225 stock average rose 41.28 points, 0.4 percent, to 10,849.57. Hong Kong's Hang Seng edged up 0.1 percent to 23,184.95 and the Shanghai Composite index gained 0.4 percent to 2,936.74.

Related Content

Breaking news
July 17, 2018
Shaked: I am staying in the Bayit Hayehudi